Continuous Renal Replacement Therapy During ECMO: More than Connecting Two Circuits
Journal of Clinical Medicine · 15.11.2026 · 15 (22) · 8949
DOI: 10.3390/jcm15228949 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 15.11.2026. Verfasst von Emanuele De Simone und 7 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Combining extracorporeal membrane oxygenation (ECMO) and continuous renal replacement therapy (CRRT) raises questions concerning vascular access, circuit pressures, anticoagulation, and kidney recovery. We describe a single-center experience and frame the findings within the contemporary literature.
Methods
Adults receiving concomitant ECMO and CRRT between January 2023 and June 2026 were retrospectively studied. Circuit performance, anticoagulation strategy, in-hospital mortality and kidney outcomes after intensive care unit discharge were described.
Results
Twenty-six patients received CRRT during ECMO; 16 were managed with an integrated configuration and 10 with a dedicated dialysis catheter. Regional citrate anticoagulation was used in 49 of 72 CRRT circuits (68.1%). Overall mortality rate was 17/26 (65.4%). Among 72 CRRT circuits delivered during ECMO support, only three (4.2%) were interrupted because of technical failure. All 11 patients who survived to ECMO discontinuation continued to require CRRT; median observed post-ECMO CRRT duration was 17 days. At 90 days after ICU discharge, five of eight survivors with available kidney function follow-up had recovered to baseline and three had new-onset CKD; none of the nine survivors remained KRT-dependent.
Conclusions
The combined use of ECMO and CRRT represents an evolving frontier of multiorgan support in a high-mortality population, in whom improving management and outcomes remains a major unmet need. This complex support requires technical expertise, an understanding of circuit interactions, and awareness of patient-specific clinical challenges and anticipated trajectories to enable individualized management. Nephrological care should therefore extend beyond circuit integration and the acute phase, encompassing kidney support and subsequent renal recovery.
Zitieren
APA
Simone, E. D., Longo, R., Boero, E., Pozzato, M., Roccatello, D., Fenoglio, R., Sciascia, S., & Kashani, K. (2026). Continuous Renal Replacement Therapy During ECMO: More than Connecting Two Circuits. Journal of Clinical Medicine, 15(22), 8949. https://doi.org/10.3390/jcm15228949
Vancouver
Simone ED, Longo R, Boero E, Pozzato M, Roccatello D, Fenoglio R, et al. Continuous Renal Replacement Therapy During ECMO: More than Connecting Two Circuits. Journal of Clinical Medicine. 2026;15(22):8949. doi:10.3390/jcm15228949
BibTeX
@article{Simone2026,
author = {Simone, Emanuele De and Longo, Roberta and Boero, Enrico and Pozzato, Marco and Roccatello, Dario and Fenoglio, Roberta and Sciascia, Savino and Kashani, Kianoush},
title = {Continuous Renal Replacement Therapy During ECMO: More than Connecting Two Circuits},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {22},
pages = {8949},
doi = {10.3390/jcm15228949}
}
EUVIMED